biomedicina slovenica


pr=Benter : 7

  1. Vouk Katja; Benter Ursula; Amonkar Mayur; Marocco Alessia; Stapelkamp Ceilidh; Pfersch Sylvie; Benjamin Laure
    Cost and economic burden of adverse events associated with metastatic melanoma treatments in five countries
    2016
  2. Benter Ursula; Amonkar Mayur; Vouk Katja; Stapelkamp C
    Cost burden of adverse effects associated with metastatic melanoma (MM) therapies in Australia
    2014
  3. Vouk Katja; Benter Ursula; Amonkar Mayur; Stapelkamp C
    Economic burden of adverse effects associated with metastatic melanoma (MM) treatments in the United Kingdom
    2014
  4. Vouk Katja; Amonkar Mayur; Benter Ursula
    Assessing the economic burden of adverse effects (AES) associated with metastatic melanoma (MM) treatments in Germany
    2014
  5. Benter Ursula; Vouk Katja; Amonkar Mayur; Pfersch Sylvie; Marocco Alessia
    Estimating the cost burden of adverse effects associated with metastatic melanoma therapies in Italy
    2014
  6. Vouk Katja; Benter Ursula; Amonkar Mayur; Pfersch Sylvie; Benjamin Laure
    Cost burden of adverse effects associated with metastatic melanoma treatments in France
    2014
  7. Knöll Stefanie A.; Mair Christoph; Benter Ursula; Vouk Katja; Standaert Baudouin
    Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
    2013


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics